Literature DB >> 2573354

Glutamine synthetase and glutaminase activities in various hepatoma cells.

T Matsuno1, H Hirai.   

Abstract

Glutamine synthetase and glutaminase activities in a series of hepatoma cells of human and rat origins were determined for comparison with normal liver tissues. Marked decrease in glutamine synthetase activity was observed in the tumor cells. Phosphate-dependent and phosphate-independent glutaminase activities were increased compared with those from normal liver tissues. Well coupled mitochondria were isolated from HuH 13 line of human hepatoma cells and human liver. Oxypolarographic tests showed that glutamine oxidation was prominent in the tumor mitochondria, while mitochondria from the liver showed a feeble glutamine oxidation. Glutamine oxidation was inhibited by prior incubation of the mitochondria with DON (6-diazo-5-oxo-L-norleucine), which inhibited mitochondrial glutaminase. These results indicate that the product of glutamine hydrolysis, glutamate, is catabolized in the tumor mitochondria to supply ATP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573354

Source DB:  PubMed          Journal:  Biochem Int        ISSN: 0158-5231


  8 in total

Review 1.  Relevance of glutamine metabolism to tumor cell growth.

Authors:  M A Medina; F Sánchez-Jiménez; J Márquez; A Rodríguez Quesada; I Núñez de Castro
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

Review 2.  Brick by brick: metabolism and tumor cell growth.

Authors:  Ralph J Deberardinis; Nabil Sayed; Dara Ditsworth; Craig B Thompson
Journal:  Curr Opin Genet Dev       Date:  2008-04-02       Impact factor: 5.578

Review 3.  The Warburg effect revisited--lesson from the Sertoli cell.

Authors:  Pedro F Oliveira; Ana D Martins; Ana C Moreira; C Yan Cheng; Marco G Alves
Journal:  Med Res Rev       Date:  2014-07-12       Impact factor: 12.944

4.  Identification of rapid turnover transcripts overexpressed in thyroid tumors and thyroid cancer cell lines: use of a targeted differential RNA display method to select for mRNA subsets.

Authors:  R Gonsky; J A Knauf; R Elisei; J W Wang; S Su; J A Fagin
Journal:  Nucleic Acids Res       Date:  1997-10-01       Impact factor: 16.971

5.  Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells.

Authors:  C Lobo; M A Ruiz-Bellido; J C Aledo; J Márquez; I Núñez De Castro; F J Alonso
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

6.  Expression of glutaminase is upregulated in colorectal cancer and of clinical significance.

Authors:  Fang Huang; Qiuyue Zhang; Hong Ma; Qing Lv; Tao Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

7.  Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma.

Authors:  Decai Yu; Xianbiao Shi; Gang Meng; Jun Chen; Chen Yan; Yong Jiang; Jiwu Wei; Yitao Ding
Journal:  Oncotarget       Date:  2015-04-10

Review 8.  The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy.

Authors:  Christian R Hoerner; Viola J Chen; Alice C Fan
Journal:  Kidney Cancer       Date:  2019-02-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.